Physician
Neurology
Dr. Patrick D. Lyden, MD
|
|
Give Review
Doctor Patrick D. Lyden, MD is an expert in the field of Neurology. He researched medicine at Baylor College of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". Patrick Lyden is a published doctor. He published 61 publications, including: 'Clinical Studies Targeting Stroke and In-Hospital Cardiac Arrest.' He is registered with Medicare and accepts Medicare payments.
Publications
- Online Tool to Improve Stratification of Adverse Events in Stroke Clinical Trials.
- Clinical Studies Targeting Stroke and In-Hospital Cardiac Arrest.
- Clinical studies targeting stroke.
- Revisiting Cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema.
- Robust and fragile aspects of cortical blood flow in relation to the underlying angioarchitecture.
- Challenges of Decision Making Regarding Futility in a Randomized Trial: The Interventional Management of Stroke III Experience.
- Mild hypothermia reduces tissue plasminogen activator-related hemorrhage and blood Brain barrier disruption after experimental stroke: editorial commentary on tang et ...
- Endovascular therapeutic hypothermia for acute ischemic stroke: ICTuS 2/3 protocol.
- Activated Protein C Analog Protects From Ischemic Stroke and Extends the Therapeutic Window of Tissue-Type Plasminogen Activator in Aged Female Mice and Hypertensive R...
- Preclinical and clinical studies targeting stroke.
- Acute Stroke Imaging Research Roadmap II.
- Pooled Assessment of Computed Tomography Interpretation by Vascular Neurologists in the STRokE DOC Telestroke Network.
- Determinants of Pneumonia Risk During Endovascular Hypothermia.
- Type of admission is associated with outcome of spontaneous subarachnoid Hemorrhage.
- PHLPP1 gene deletion protects the Brain from ischemic injury.
- Concurrent middle cerebral artery occlusion and intra-arterial drug infusion via ipsilateral common Carotid artery catheter in the rat.
- The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit.
- β-adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, and inflammatory response after traumatic Brain injury.
- Eagle Syndrome revisited: cerebrovascular complications.
- Determinants of effective cooling during endovascular hypothermia.
- Thrombin Activity Associated with Neuronal Damage during Acute Focal Ischemia.
- Frequent Early Cardiac Complications Contribute to Worse Stroke Outcome in Atrial Fibrillation.
- Advanced Brain Imaging Studies Should Not Be Performed in Patients With Suspected Stroke Presenting Within 4.5 Hours of Symptom Onset.
- COMMENTARY: The Endovascular Procedure-Specific Neurological Examination Scheme.
- Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials.
- Thrombin mediates severe neurovascular injury during ischemia.
- ACCESS: acute Cerebrovascular care in emergency stroke systems.
- Analysis of the National Institute of Neurological Disorders and Stroke tissue plasminogen activator studies following European Cooperative Acute Stroke Study III pati...
- An ethical hierarchy for decision making during medical emergencies.
- Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke...
- Severe blood-Brain barrier disruption and surrounding tissue injury.
- Correlations of neuronal and microvascular densities in murine cortex revealed by direct counting and colocalization of nuclei and vessels.
- Premature closure of the TUCSON trial: Stroke research is not for the faint of heart.
- Development of the Italian version of the National Institutes of Health Stroke Scale: It-NIHSS.
- Acute vascular disruption and aquaporin 4 loss after stroke.
- Active dilation of penetrating arterioles restores red blood cell flux to penumbral neocortex after focal stroke.
- Prior antiplatelet use does not affect Hemorrhage growth or outcome after ICH.
- Multimodal neuroprotective therapy with induced hypothermia after ischemic stroke.
- Hypothermia after acute ischemic stroke.
- Selecting a measurement model for the analysis of the National Institutes of Health Stroke Scale.
- The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attack.
- Code stroke in the cath lab.
- Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center.
- Effect of endovascular hypothermia on acute ischemic edema: morphometric analysis of the ICTuS trial.
- Stroke-evoked angiogenesis results in a transient population of microvessels.
- Induced hypothermia for acute stroke.
- Penetrating arterioles are a bottleneck in the perfusion of neocortex.
- An expedited code stroke protocol is feasible and safe.
- A trial of therapeutic hypothermia via endovascular approach in awake patients with acute ischemic stroke: methodology.
- Contraindications of VEGF-based therapeutic angiogenesis: effects on macrophage density and histology of normal and ischemic Brains.
- Targeted insult to subsurface cortical blood vessels using ultrashort laser pulses: three models of stroke.
- Two-photon imaging of cortical surface microvessels reveals a robust redistribution in blood flow after vascular occlusion.
- Intravascular Cooling in the Treatment of Stroke (ICTuS): early clinical experience.
- Thrombosis of the posterior cerebral Artery (PCA) visualized on computed tomography: the dense PCA sign.
- Neuroprotection of ischemic Brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis.
- Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity.
- Systematic review of nimodipine.
- Acute medical therapy.
- The clomethiazole acute stroke study in ischemic, hemorrhagic, and t-PA treated stroke: Design of a phase III trial in the united states and canada.
- Phase 1 Safety, Tolerability and Pharmacokinetics of 3K3A-APC in Healthy Adult Volunteers.
Schools
Baylor University
Scripps Mercy Hospital
University Ca San Diego Med Center
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Autonomic Disorders
- Brachial Plexus Palsy
- View All
Doctors Specialties
- Vascular Neurology
- Neurology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of California San Diego -
Scripps Mercy Hospital -
Baylor College of Medicine
Hospital
-
Cedars-Sinai Medical Center -
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1215962113 | |
| NPPES Provider LastName | LYDEN | |
| NPPES Provider FirstName | PATRICK | |
| NPPES Provider ZIPCode | 900481804 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurology | |
| Total Claim Count | 180.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1215962113 |
| Last Name Of The Provider | LYDEN |
| First Name Of The Provider | PATRICK |
| View All |
Similar Doctors
|
|
Dr. Harley I. Kornblum, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Nicholas J. Parziale, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert E. Adams, MD |
|
|
Dr. Jeffrey L. Saver, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sebina Bulic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aylin Y. Reid, MD |
|
|
Dr. Mohammad S. Shafie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Christian Herrmann |